Inflammatory Bowel Disease (IBD)

Inflammatory bowel disease (IBD) is an umbrella term for a group of chronic conditions that cause swelling and inflammation of the tissues in the digestive tract. IBD is not a single disease — it describes persistent inflammation that can damage the gastrointestinal tract over time, disrupt daily life, and in severe cases, lead to serious complications.

The two most common types of IBD are ulcerative colitis and Crohn's disease. Ulcerative colitis involves inflammation and ulcers (sores) along the lining of the colon and rectum. Crohn's disease, on the other hand, can affect any part of the digestive tract — most commonly the small intestine — and often penetrates deeper layers of the bowel wall.

Signs of IBD: Recognizing the Symptoms

Inflammatory bowel disease symptoms can range from mild to severe and often follow a pattern of flare-ups and remission. The most common signs of IBD include:

• Diarrhea — often persistent and sometimes urgent
• Abdominal pain and cramping — frequently in the lower or central abdomen
• Blood in the stool — a key distinguishing sign of IBD in comparison to IBS
• Unintended weight loss
• Loss of appetite
• Extreme fatigue

IBD Symptoms in Females

While IBD affects both men and women, IBD symptoms in females can present with some unique challenges. Women with IBD may experience worsening symptoms around their menstrual cycle due to hormonal fluctuations. IBD can also affect fertility and pregnancy outcomes, making early diagnosis and careful disease management especially important for women of reproductive age. Iron-deficiency anemia — a result of chronic rectal bleeding and poor nutrient absorption — is also particularly common in women with IBD.

IBD vs. IBS: Understanding the Difference

One of the most searched topics in gut health is the difference between IBD and IBS (irritable bowel syndrome). Although their names sound similar and they share some overlapping symptoms, they are fundamentally different conditions.

IBD (Inflammatory Bowel Disease) is a chronic inflammatory disease with measurable damage to the digestive tract. It can be confirmed through imaging, endoscopy, and lab tests. IBS (Irritable Bowel Syndrome) is a functional disorder — meaning there is no visible inflammation or tissue damage. IBS is diagnosed based on symptoms alone, after other causes have been ruled out.

IBS symptoms such as bloating, cramping, and changes in bowel habits can mimic IBD symptoms, but IBS does not cause rectal bleeding, significant weight loss, or the kind of tissue damage seen in IBD. If you are experiencing persistent or severe gut symptoms, it is essential to get a proper diagnosis rather than assuming one condition over the other.

Causes of IBD

The exact causes of IBD are not fully understood, but research points to a combination of factors:

• Immune system dysfunction plays a central role. In people with IBD, the immune system mistakenly attacks the cells lining the digestive tract while trying to fight off bacteria or viruses, leading to chronic inflammation.
• Genetic factors also contribute. Several genetic markers have been associated with IBD, and the condition is more common in people who have a first-degree relative — a parent, sibling, or child — with the disease.
• Environmental triggers are believed to influence the development of IBD by affecting the gut microbiome. These may include limited exposure to germs in early childhood, a gastrointestinal infection early in life, antibiotic use in the first year of life, and being predominantly bottle-fed as an infant.

Risk Factors for IBD

Certain factors can increase a person's likelihood of developing inflammatory bowel disease:

• Age: Most people are diagnosed before age 30, though IBD can develop in the 50s or 60s as well
• Family history: Having a blood relative with IBD significantly raises your risk
• Smoking: The most important controllable risk factor for Crohn's disease specifically
• Use of NSAIDs: Non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen can worsen IBD or increase the risk of developing it
• Race and ethnicity: IBD is more prevalent in white populations but is rising across all ethnicities globally

IBD and Tissue Transglutaminase (tTG)

Patients with IBD are sometimes tested for tissue transglutaminase (tTG) antibodies as part of a broader diagnostic workup. This is because IBD and celiac disease can co-exist, and their symptoms overlap significantly. Elevated tTG-IgA antibodies indicate an immune response to gluten characteristic of celiac disease. Distinguishing between the two conditions, or identifying when both are present, is critical for determining the right dietary and medical treatment plan.

How Is IBD Diagnosed?

Diagnosing IBD typically requires a combination of tests:

• Blood tests to check for anemia, infection, and markers of inflammation
• Stool studies to rule out infection and measure inflammatory markers like calprotectin
• Colonoscopy— the most common method for IBD diagnosis, allowing direct visualization and tissue biopsy
• Flexible sigmoidoscopy for examination of the lower colon
• CT or MRI enterography for detailed imaging of the small intestine and surrounding tissue
• Capsule endoscopy to examine the small bowel when other methods are insufficient

Inflammatory Bowel Disease Treatment

The primary goal of inflammatory bowel disease treatment is to reduce inflammation, achieve remission, and prevent complications. Treatment is tailored to the type and severity of IBD and may include:

Anti-Inflammatory Medicines

Aminosalicylates (such as mesalamine) are commonly used as a first-line treatment for mild to moderate ulcerative colitis. Corticosteroids may be used short-term to bring active flares under control.

Immunomodulators

These medications suppress the overactive immune response responsible for inflammation. Common examples include azathioprine, mercaptopurine, and methotrexate.

Biologic therapies

Biologic therapies target specific proteins involved in the inflammatory process. Medications such as infliximab (Remicade), adalimumab (Humira), vedolizumab (Entyvio), and ustekinumab (Stelara) are administered by injection or IV infusion and are used for moderate to severe IBD.

Small Molecule Therapies

A newer class of oral medications — including JAK inhibitors like tofacitinib (Xeljanz) and upadacitinib (Rinvoq), and S1P receptor modulators like ozanimod (Zeposia) — offer additional options for patients who do not respond to biologics. Note: the FDA has issued a safety warning regarding tofacitinib related to increased cardiovascular disease (CVD) and cancer risk. Always consult your physician before making changes to this medication.

Antibiotics

Used when there is evidence of infection or perianal disease, commonly ciprofloxacin and metronidazole.

Surgery

When medications fail to control IBD, surgery may be necessary. For ulcerative colitis, surgery typically involves removing the colon and rectum. For Crohn's disease, surgery removes damaged segments of the bowel, though it is not curative and disease recurrence near the reconnected tissue is common.

Inflammatory Bowel Disease Diet

There is no single inflammatory bowel disease diet that works for everyone, but nutrition plays a vital supporting role in managing symptoms and maintaining overall health. General dietary guidance includes:

• During flares: A low-residue or low-fiber diet can reduce bowel irritation and minimize the risk of blockages in areas of narrowing
• For nutrient deficiencies: Vitamins and nutritional supplements are often necessary, as IBD impairs nutrient absorption
• Avoiding triggers: Common culprits include spicy foods, high-fat meals, caffeine, alcohol, and dairy — though triggers vary from person to person
• Enteral or parenteral nutrition: In cases of significant weight loss or severe flares, medically supervised liquid nutrition (via feeding tube or IV) may be required to allow the bowel to rest and recover

Always consult your gastroenterologist or a registered dietitian before making significant dietary changes, as needs vary greatly depending on which part of the bowel is affected and disease severity.

IBD Prognosis: What to Expect Long-Term

IBD prognosis varies widely depending on the type of IBD, disease severity, and how well it responds to treatment. Many patients achieve long periods of remission with appropriate medical management and lead full, active lives. However, IBD is a lifelong condition — there is currently no cure for Crohn's disease, and while surgery can effectively eliminate ulcerative colitis, it comes with its own long-term considerations.

Regular follow-up with a gastroenterologist, adherence to prescribed IBD medications, and healthy lifestyle habits all contribute significantly to better long-term outcomes.

End-Stage Inflammatory Bowel Disease

In a small proportion of patients, IBD progresses to a severe, refractory state sometimes referred to as end-stage inflammatory bowel disease. This is characterized by continuous, uncontrolled inflammation that does not respond to medical therapies, leading to serious complications such as bowel obstruction, fistulas, abscesses, toxic megacolon, perforated colon, or significantly increased risk of colorectal cancer. At this stage, surgical intervention is often unavoidable.

When to See a Specialist

You should seek medical evaluation if you experience any of the following:

• Persistent diarrhea lasting more than a few days
• Blood in your stool
• Unexplained weight loss
• Ongoing abdominal pain or cramping
• Chronic fatigue with no clear cause

Early diagnosis and treatment are key to preventing disease progression and protecting your quality of life. If you suspect you may have IBD, do not delay — contact a gastroenterology specialist for a comprehensive evaluation.

Expert Gastroenterological Care at Medical Park

At Medical Park Hospitals in Turkey, both local and international patients with inflammatory bowel disease receive world-class gastroenterological care under one roof. Our experienced gastroenterologists use the latest diagnostic technologies — including advanced endoscopy, MRI enterography, and comprehensive laboratory testing — to accurately diagnose and stage IBD, whether it presents as Crohn's disease, ulcerative colitis, or a more complex overlapping condition.

We offer fully individualized IBD treatment plans that bring together the most current medical therapies, including biologic agents and small molecule treatments, alongside expert nutritional support and surgical expertise when required. Our multidisciplinary team approach ensures that every dimension of your condition — from managing active flares to long-term remission strategy — is addressed with precision and continuity of care.

With hospitals across Istanbul and throughout the country, our facilities are equipped with internationally accredited standards, English-speaking medical staff, and dedicated patient coordinators to support you from your first consultation through every stage of treatment. If you are living with IBD symptoms, seeking a second opinion, or looking for advanced IBD therapy options, Medical Park is here to help. Contact us today to schedule a consultation with our specialists.